NDC 68788-0241

Lorazepam

Lorazepam

Lorazepam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Lorazepam.

Product ID68788-0241_9b6c9699-5c8c-4620-b22d-23e261b9faa8
NDC68788-0241
Product TypeHuman Prescription Drug
Proprietary NameLorazepam
Generic NameLorazepam
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-08-27
Marketing CategoryANDA / ANDA
Application NumberANDA072927
Labeler NamePreferred Pharmaceuticals, Inc.
Substance NameLORAZEPAM
Active Ingredient Strength1 mg/1
Pharm ClassesBenzodiazepine [EPC],Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68788-0241-6

60 TABLET in 1 BOTTLE, PLASTIC (68788-0241-6)
Marketing Start Date2013-08-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-0241-1 [68788024101]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-27
Marketing End Date2019-10-23

NDC 68788-0241-8 [68788024108]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-27
Marketing End Date2019-10-23

NDC 68788-0241-6 [68788024106]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-27
Marketing End Date2019-10-23

NDC 68788-0241-5 [68788024105]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-27
Marketing End Date2019-10-23

NDC 68788-0241-3 [68788024103]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-27
Marketing End Date2019-10-23

NDC 68788-0241-9 [68788024109]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA072927
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-27
Marketing End Date2019-10-23

Drug Details

Active Ingredients

IngredientStrength
LORAZEPAM1 mg/1

OpenFDA Data

SPL SET ID:47baa471-b3b5-431b-a2e5-e302c4c7a8f8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197901
  • Pharmacological Class

    • Benzodiazepine [EPC]
    • Benzodiazepines [CS]

    NDC Crossover Matching brand name "Lorazepam" or generic name "Lorazepam"

    NDCBrand NameGeneric Name
    0054-3532LorazepamLorazepam
    0093-3425LorazepamLorazepam
    0093-3426LorazepamLorazepam
    0093-3427LorazepamLorazepam
    0121-0770LorazepamLorazepam
    67544-982LorazepamLorazepam
    0409-6779LorazepamLorazepam
    0409-6778LorazepamLorazepam
    0409-6780LorazepamLorazepam
    68071-3010LorazepamLorazepam
    68071-3227LorazepamLorazepam
    68071-3121LorazepamLorazepam
    68071-3242LorazepamLorazepam
    68071-3096LorazepamLorazepam
    68084-736LorazepamLorazepam
    68084-742LorazepamLorazepam
    68084-754LorazepamLorazepam
    68788-0241LorazepamLorazepam
    68788-9511LorazepamLorazepam
    68788-7355LorazepamLorazepam
    68788-7411LorazepamLorazepam
    68788-9839LorazepamLorazepam
    68788-9258LorazepamLorazepam
    68788-9840LorazepamLorazepam
    68788-9982LorazepamLorazepam
    69315-904LorazepamLorazepam
    69315-906LorazepamLorazepam
    69315-905LorazepamLorazepam
    0591-0240LorazepamLorazepam
    0591-0241LorazepamLorazepam
    0591-0242LorazepamLorazepam
    70518-0155LorazepamLorazepam
    70518-0486LorazepamLorazepam
    70518-0275LorazepamLorazepam
    70518-0156LorazepamLorazepam
    70518-0445LorazepamLorazepam
    70518-1045LorazepamLorazepam
    70518-1431LorazepamLorazepam
    70518-1520LorazepamLorazepam
    70518-1313LorazepamLorazepam
    70518-1679LorazepamLorazepam
    70518-1255LorazepamLorazepam
    0603-4246LorazepamLorazepam
    71205-200LorazepamLorazepam
    71205-235LorazepamLorazepam
    71205-228LorazepamLorazepam
    71205-166LorazepamLorazepam
    71335-0277LorazepamLorazepam
    71335-0655LorazepamLorazepam
    71335-0204LorazepamLorazepam

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.